Laurent Humeau - Mar 11, 2022 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Signature
/s/ Laurent Humeau
Stock symbol
INO
Transactions as of
Mar 11, 2022
Transactions value $
-$66,519
Form type
4
Date filed
3/14/2022, 04:50 PM
Previous filing
Mar 9, 2022
Next filing
Feb 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INO Common Stock Options Exercise +59.7K +62.48% 155K Mar 11, 2022 Direct F1
transaction INO Common Stock Tax liability -$66.5K -20.7K -13.3% $3.22* 135K Mar 11, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INO Restricted Stock Unit Options Exercise $0 -59.7K -50% $0.00 59.7K Mar 11, 2022 Common Stock 59.7K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.